We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
-6.29%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$303M
AUM Growth
-$74M
Cap. Flow
-$25.6M
Cap. Flow %
-8.44%
Top 10 Hldgs %
23.13%
Holding
160
New
47
Increased
41
Reduced
24
Closed
48

Top Sells

Rank Stock Value
1
PRFT
Perficient Inc
PRFT
+$8.1M
2
BOOT icon
Boot Barn
BOOT
+$6.54M
3
STAA icon
STAAR Surgical
STAA
+$6.29M
4
VIAV icon
Viavi Solutions
VIAV
+$6.26M
5
LAD icon
Lithia Motors
LAD
+$6.2M

Sector Composition

Rank Sector Weight
1 Technology 26.29%
2 Healthcare 24.35%
3 Industrials 22.77%
4 Consumer Discretionary 10.43%
5 Financials 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDOT icon
76
Green Dot
GDOT
$745M
$1.47M 0.48%
+57,820
New +$1.66M
JBTM
77
JBT Marel
JBTM
$6.39B
$1.46M 0.48%
+19,685
New +$1.97M
GSHD icon
78
Goosehead Insurance
GSHD
$2.32B
$1.44M 0.48%
+32,250
New +$1.6M
TXRH icon
79
Texas Roadhouse
TXRH
$13.7B
$1.31M 0.43%
31,680
+22,271
+237% +$1.23M
ZM icon
80
Zoom
ZM
$30.6B
$1.29M 0.43%
+8,820
New +$870K
AEIS icon
81
Advanced Energy
AEIS
$13B
$1.24M 0.41%
25,610
-51,996
-67% -$3.3M
MPWR icon
82
Monolithic Power Systems
MPWR
$68.9B
$1.18M 0.39%
7,038
+232
+3% +$39.8K
MYOK
83
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$1.09M 0.36%
+23,220
New +$1.49M
KRTX
84
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.08M 0.36%
+15,010
New +$1.28M
SWAV
85
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$1.07M 0.35%
32,340
+1,419
+5% +$56.4K
ATRC icon
86
AtriCure
ATRC
$2.11B
$1.02M 0.34%
+30,435
New +$1.09M
PATK icon
87
Patrick Industries
PATK
$2.85B
$1.02M 0.34%
+54,165
New +$1.72M
JBLU icon
88
JetBlue
JBLU
$2.29B
$933K 0.31%
+104,195
New +$1.73M
CSGP icon
89
CoStar Group
CSGP
$12.3B
$917K 0.3%
+15,610
New +$1.02M
PTON icon
90
Peloton Interactive
PTON
$2.49B
$911K 0.3%
34,315
+11,016
+47% +$306K
TGTX icon
91
TG Therapeutics
TGTX
$7.62B
$907K 0.3%
+92,150
New +$1.16M
ALK icon
92
Alaska Air
ALK
$5.58B
$887K 0.29%
+31,140
New +$1.69M
NBIX icon
93
Neurocrine Biosciences
NBIX
$16.6B
$839K 0.28%
9,695
-741
-7% -$72.5K
BILL icon
94
BILL Holdings
BILL
$4.78B
$812K 0.27%
23,755
-7,540
-24% -$357K
DCPH
95
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$761K 0.25%
+18,490
New +$1.03M
APLS
96
DELISTED
Apellis Pharmaceuticals
APLS
$759K 0.25%
+28,350
New +$1.01M
CDLX icon
97
Cardlytics
CDLX
$21.5M
$721K 0.24%
2,062
-1,351
-40% -$957K
CRSP icon
98
CRISPR Therapeutics
CRSP
$5.17B
$708K 0.23%
16,690
+7,175
+75% +$370K
SRPT icon
99
Sarepta Therapeutics
SRPT
$1.77B
$639K 0.21%
+6,532
New +$747K
PPD
100
DELISTED
PPD, Inc. Common Stock
PPD
$633K 0.21%
+35,540
New +$892K

Similar funds

Lisanti Capital Growth's Q1 2020 Portfolio in Review

As of Q1 2020, Lisanti Capital Growth held 160 positions worth $303M, down 20% from $377M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lisanti Capital Growth withdrew a net $25.6M in Q1 2020, closing 48 positions and reducing 24 holdings. Its most notable exit was Perficient Inc, an estimated $8.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in FTI Consulting worth $6.26M.

  • Lisanti Capital Growth's largest Q1 2020 buy was FTI Consulting: 52,308 shares worth $6.26M.
  • Lisanti Capital Growth added most to SolarEdge in Q1 2020, an estimated $4.65M increase.
  • Lisanti Capital Growth's biggest Q1 2020 reduction was Teladoc Health, cutting an estimated $5.85M.
  • Lisanti Capital Growth fully exited Perficient Inc in Q1 2020, selling an estimated $8.1M.
  • Lisanti Capital Growth's ten largest holdings make up 23% of its $303M portfolio in Q1 2020.
  • Lisanti Capital Growth opened 47 new positions and closed 48 in Q1 2020.
  • Lisanti Capital Growth's portfolio value fell 20% quarter-over-quarter to $303M.

Based on Lisanti Capital Growth's 13F filing for Q1 2020, filed 11 May 2020.